"Part of this decline is due to lower anticipated commitments from Halozyme (our largest customer) based on their most recent committed forecast (covering the 3 qtrs ending March 2018), which amount is expected to be partially offset by $10mm revenue that was expected to be recognized in FY17"
YIKES! The $10m "shift" in revenue is only going to partially offset the decrease in Halozyme revenue.
The going concern is making more sense. Lowering forecasts for sure going forward.